Cargando…
264. COVID-19 Associated Pulmonary Aspergillosis in Intensive Care Patients Based on Duration of Corticosteroid Administration
BACKGROUND: Coronavirus disease 2019 (COVID-19) associated pulmonary aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. Corticosteroids are standard of care for COVID-19 patients. Prolonged corticosteroids have been associated with an increased risk of CAPA, but...
Autores principales: | Shah, Meera D, Christina Gutierrez, G, Moote, Rebecca, Reveles, Kelly R, Hand, Elizabeth O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751639/ http://dx.doi.org/10.1093/ofid/ofac492.342 |
Ejemplares similares
-
Risk of Coronavirus Disease 2019–Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients
por: Shah, Meera, et al.
Publicado: (2023) -
2804. Azole versus echinocandin combination therapy for the treatment of invasive mucormycosis: A case series
por: Shah, Meera, et al.
Publicado: (2023) -
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
por: Leistner, Rasmus, et al.
Publicado: (2022) -
499. Immunotherapy with Pattern Recognition Receptor Agonists Improves Morbidity and Mortality in a Corticosteroid-Immunosuppressed Murine Model of Influenza-Associated Pulmonary Aspergillosis
por: Wurster, Sebastian, et al.
Publicado: (2022) -
2264. Shorter Duration of Visit Associated with Inappropriate Antibiotic Prescribing for Respiratory Tract Infections in a National Sample of Ambulatory Visits, 2009 - 2016
por: Mendoza, Vidal M, et al.
Publicado: (2023)